Literature DB >> 18621125

Transport of amino acids and GABA analogues via the human proton-coupled amino acid transporter, hPAT1: characterization of conditions for affinity and transport experiments in Caco-2 cells.

Mie Larsen1, Birger Brodin Larsen, Bente Frølund, Carsten Uhd Nielsen.   

Abstract

The objective of this study was to investigate transepithelial amino acid transport as a function of Caco-2 cell culture time. Furthermore, the objective was to investigate apical uptake characteristics of hPAT1-mediated transport under various experimental conditions. Apical amino acid uptake and transport studies were conducted in Caco-2 monolayers cultured for 4-28 days. Transepithelial transport of the prototypic hPAT1 (SLC36A1) substrates l-proline and glycine were maximal after 21-28 days in culture. Based on proton-dependency and substrate kinetics the major apical uptake and transport of Gly and Pro in Caco-2 cell monolayers is hPAT1-mediated. The apical uptake of Pro is decreased at apical hyperosmolarity conditions. Furthermore we identified the two GABA-analogues, muscimol and THPO as novel hPAT1 substrates. THPO had an affinity for hPAT1 of 11.3mM, whereas muscimol had one of the highest affinities for hPAT1 (1.7mM) reported. Our findings illustrate the suitability of the Caco-2 model for studying hPAT1-mediated transport. Furthermore, the affinity of THPO and muscimol underlines the possible importance of hPAT1 as a transporter for heterocyclic compounds consisting of a 3-isoxazolol moiety, which has been shown to function as a carboxylic acid bioisostere for substrates of the GABA receptor and transport systems.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18621125     DOI: 10.1016/j.ejps.2008.06.007

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  14 in total

Review 1.  The SLC36 family of proton-coupled amino acid transporters and their potential role in drug transport.

Authors:  David T Thwaites; Catriona M H Anderson
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

2.  Soluplus--solubilized citrated camptothecin--a potential drug delivery strategy in colon cancer.

Authors:  Naveen K Thakral; Alok R Ray; Daniel Bar-Shalom; André Huss Eriksson; Dipak K Majumdar
Journal:  AAPS PharmSciTech       Date:  2011-11-22       Impact factor: 3.246

3.  In vivo and in vitro evaluations of intestinal gabapentin absorption: effect of dose and inhibitors on carrier-mediated transport.

Authors:  Malte Selch Larsen; Sidsel Frølund; Martha Kampp Nøhr; Carsten Uhd Nielsen; Mats Garmer; Mads Kreilgaard; René Holm
Journal:  Pharm Res       Date:  2014-09-03       Impact factor: 4.200

4.  The proton-coupled amino acid transporter, SLC36A1 (hPAT1), transports Gly-Gly, Gly-Sar and other Gly-Gly mimetics.

Authors:  S Frølund; R Holm; B Brodin; C U Nielsen
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

5.  Intestinal gaboxadol absorption via PAT1 (SLC36A1): modified absorption in vivo following co-administration of L-tryptophan.

Authors:  M Larsen; R Holm; K G Jensen; B Brodin; C U Nielsen
Journal:  Br J Pharmacol       Date:  2009-07-07       Impact factor: 8.739

6.  Delta-aminolevulinic acid is a substrate for the amino acid transporter SLC36A1 (hPAT1).

Authors:  S Frølund; O C Marquez; M Larsen; B Brodin; C U Nielsen
Journal:  Br J Pharmacol       Date:  2010-01-27       Impact factor: 8.739

7.  Sertraline inhibits the transport of PAT1 substrates in vivo and in vitro.

Authors:  C U Nielsen; S Frølund; S Abdulhadi; H Sari; L Langthaler; M K Nøhr; M A Kall; B Brodin; R Holm
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

8.  Identification of a disulfide bridge essential for transport function of the human proton-coupled amino acid transporter hPAT1.

Authors:  Madlen Dorn; Matthias Weiwad; Fritz Markwardt; Linda Laug; Rainer Rudolph; Matthias Brandsch; Eva Bosse-Doenecke
Journal:  J Biol Chem       Date:  2009-06-23       Impact factor: 5.157

9.  Function and expression of the proton-coupled amino acid transporter PAT1 along the rat gastrointestinal tract: implications for intestinal absorption of gaboxadol.

Authors:  M l Broberg; R Holm; H Tønsberg; S Frølund; K B Ewon; A l Nielsen; B Brodin; A Jensen; M A Kall; K V Christensen; C U Nielsen
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

10.  The quest for targeted delivery in colon cancer: mucoadhesive valdecoxib microspheres.

Authors:  Naveen K Thakral; Alok R Ray; Daniel Bar-Shalom; André Huss Eriksson; Dipak K Majumdar
Journal:  Int J Nanomedicine       Date:  2011-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.